Case series of catheter-based arrhythmia ablation in pregnant women

Autor: S Mladoniczky, Z S Nagy, C S Foldesi, Z Som, O H Balint, L Kornyei, T Simor, D Ruzsa, E Fodi, A Kardos

Publikováno v: Europace. 25

Funding Acknowledgements Type of funding sources: None. Background Antiarrhythmic drugs (AADs) should be used with caution in treating arrhythmias during pregnancy because of side effects, but catheter ablation is a rarely used procedure. Aim To inve

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7266face80c7601a99ea9d66c08df5ce
https://doi.org/10.1093/europace/euad122.708

Electroanatomical mapping-system guided vs. intracardiac echocardiography-guided slow pathway ablation: a randomized, single-center trial

Autor: B Bocz, D Debreceni, K Janosi, T Simor, P Kupo

Publikováno v: Europace. 25

Funding Acknowledgements Type of funding sources: None. Introduction Radiofrequency (RF) catheter ablation of the slow pathway (SP) in atrioventricular nodal reentry tachycardia (AVNRT) is highly effective; however, it may require prolonged fluorosco

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::83ecc31ed803488fc99091ce92450afa
https://doi.org/10.1093/europace/euad122.240

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Comparison of intracardiac echocardiography-guided versus conventionally performed cavotricuspidal isthmus ablation in patients with atrial flutter

Autor: K Janosi, D Debreceni, M Turcsan, T Simor, P Kupo

Publikováno v: EP Europace. 24

Funding Acknowledgements Type of funding sources: None. Background Cavotricuspidal isthmus (CTI) is the target of the catheterablation for patients with typical atrial flutters. Intracardiac echocardiography (ICE) allows safe, real-time visualization

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::225c6bf306b9fff59d785368af9a195d
https://doi.org/10.1093/europace/euac053.316

Bucindolol Decreases Atrial Fibrillation Burden in Patients With Heart Failure and the ADRB1 Arg389Arg Genotype

Autor: Jonathan P. Piccini, Christopher Dufton, Ian A. Carroll, Jeff S. Healey, William T. Abraham, Yaariv Khaykin, Ryan Aleong, Steven K. Krueger, William H. Sauer, Stephen B. Wilton, Michiel Rienstra, Dirk J. van Veldhuisen, Inder S. Anand, Michel White, A. John Camm, Paul D. Ziegler, Debra Marshall, Michael R. Bristow, Stuart J. Connolly, F Ayala-Paredes, A Bakbak, ML Bernier, DH Birnie, B Coutu, E Crystal, MW Deyell, KM Dyrda, MC Hartleib, ZW Laksman, P Leong-Sit, CA Morillo, AS Pandey, F Philippon, S Vizel, P Andréka, Z Csanadi, GZ Duray, T Forster, G Kerkovits, B Merkely, AC Nagy, T Simor, D Czarnecka, JD Kasprzak, WJ Musial, G Raczak, J Szachniewicz, JK Wranicz, S Apostolović, S Hinić, V Miloradović, D Simić, GJ Milhous, A Oomen, TJ Romer, LM van Vijk, PB Adamson, JD Allred, N Amjadi, MM Bahu, AJ Bank, AE Berman, MA Bernabei, RS Bhagwat, L Borgatta, AJ Buda, RT Cole, JL Collier, SJ Compton, O Costantini, MR Costanzo, IM Dauber, MP Donahue, I Dor, GF Egnacyzk, EJ Eichhorn, CC Eiswirth, S Emani, GA Ewald, RC Forde-McLean, MD Gelernt, DE Haines, CA Henrikson, JM Herre, B Herweg, L Ilkhanoff, LR Jackson, A Lala, R Lo, B London, BD Lowes, JA Mackall, V Malhotra, FA McGrew, S Murali, A Natale, KR Nilsson, J Okolo, MV Perez, RS Phang, R Ranjan, MY Rashtian, MJ Ross, SM Samii, T Shinn, MB Shoemaker, SA Strickberger, VN Tholakanahalli, A Tzur, PJ Wang, LT Younis

Publikováno v: Circulation. Arrhythmia and Electrophysiology, 14(8):009591. LIPPINCOTT WILLIAMS & WILKINS

Background: Bucindolol is a genetically targeted β-blocker/mild vasodilator with the unique pharmacological properties of sympatholysis and ADRB1 Arg389 receptor inverse agonism. In the GENETIC-AF trial (Genotype-Directed Comparative Effectiveness T

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35b3b46d4e71ba0e2188b0ff7e480073
https://research.rug.nl/en/publications/e4da658b-c78f-4c9f-a6ea-3c34cd1b9426